Hirschel BJ - Search Results

1

Controversies: does the CD4+ cell count reflect clinical efficacy?

Kinloch-de-Loës S, Perrin LH, Hirschel BJ, Perneger TV. Kinloch-de-Loës S, et al. Among authors: hirschel bj. JAMA. 1996 Oct 16;276(15):1219; author reply 1919-20. doi: 10.1001/jama.276.15.1219. JAMA. 1996. PMID: 8849744 No abstract available.

2

A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study.

Yerly S, Perneger TV, Hirschel B, Dubuis O, Matter L, Malinverni R, Furrer H, Perrin L. Yerly S, et al. Arch Intern Med. 1998 Feb 9;158(3):247-52. doi: 10.1001/archinte.158.3.247. Arch Intern Med. 1998. PMID: 9472204

3

[Primary HIV infection: an often suspected diagnosis but confirmed late].

Galetto-Lacour A, Kinloch-de Loës S, Hirschel B, Perrin L. Galetto-Lacour A, et al. Schweiz Med Wochenschr. 1995 Feb 25;125(8):341-6. Schweiz Med Wochenschr. 1995. PMID: 7709182 French.

4

The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individual.

Vanhems P, Caillat-Vallet E, Hirschel B, Routy JP, Carr A, Vizzard J, Cooper DA, Perrin L; Swiss HIV Cohort Study. Vanhems P, et al. AIDS. 2002 Nov 8;16(16):2234-6. doi: 10.1097/00002030-200211080-00022. AIDS. 2002. PMID: 12409751 No abstract available.

5

Biphasic decline of CD4 cell count during scheduled treatment interruptions.

Fagard C, Bandelier CY, Ananworanich J, Le Braz M, Günthard H, Perneger T, García F, Hirschel B; Staccato/SSITT Study Group. Fagard C, et al. AIDS. 2005 Mar 4;19(4):439-41. doi: 10.1097/01.aids.0000161774.29029.0e. AIDS. 2005. PMID: 15750398

6

Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.

Yerly S, Kaiser L, Baumberger C, Hirschel B, Perrin LH. Yerly S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 1;8(4):358-64. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7882100

7

The risk of HIV transmission by screened blood.

Kinloch S, Perrin L, Hirschel B. Kinloch S, et al. N Engl J Med. 1996 Apr 11;334(15):992; author reply 993. doi: 10.1056/NEJM199604113341516. N Engl J Med. 1996. PMID: 8596611 No abstract available.

8

Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group.

Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L. Galetto-Lacour A, et al. J Infect Dis. 1996 Jun;173(6):1388-93. doi: 10.1093/infdis/173.6.1388. J Infect Dis. 1996. PMID: 8648210

9

Combined therapy with zidovudine and L-697,661 in primary HIV infection.

Perrin L, Rakik A, Yerly S, Baumberger C, Kinloch-de Loës S, Pechère M, Hirschel B. Perrin L, et al. AIDS. 1996 Sep;10(11):1233-7. doi: 10.1097/00002030-199609000-00009. AIDS. 1996. PMID: 8883585

10

Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study.

Yerly S, Kaiser L, Perneger TV, Cone RW, Opravil M, Chave JP, Furrer H, Hirschel B, Perrin L. Yerly S, et al. AIDS. 2000 Feb 18;14(3):243-9. doi: 10.1097/00002030-200002180-00006. AIDS. 2000. PMID: 10716500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters